Paper II — 2024 December (Supplementary) (2019 Scheme) — Qxv
2 min read
Paper II
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min
Question
Diphtheria vaccine is a
a) Subunit vaccine
b) Toxoid vaccine
c) Whole cell vaccine
d) Recombinant vaccine
Question numbers (xvi) – (xx) consists of two Statements-Assertion (A) and Reason (R). Answer these
questions by selecting the appropriate options given below.
Qxv1 marksMCQs
Answer
- [x] b) Toxoid vaccine
The diphtheria vaccine is a toxoid vaccine — diphtheria exotoxin is chemically inactivated (with formaldehyde) to remove its toxicity while retaining its immunogenicity, so that the immune response is directed against the toxin itself (neutralizing future toxin exposure), rather than against the whole bacterium. It is not a subunit vaccine (which would use a specific bacterial/viral protein antigen unrelated to toxin neutralization), whole cell vaccine (which uses the entire inactivated/killed organism), or recombinant vaccine (produced via genetic engineering, unrelated to the classical toxoid preparation method used for diphtheria).